Anixa Biosciences Inc (ANIX) stock: 12-month forecast projects 126.59% potential return%

Anixa Biosciences Inc [ANIX] stock is trading at $3.31, down -0.30%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ANIX shares have gain 8.70% over the last week, with a monthly amount drifted -16.20%, and not seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Anixa Biosciences Inc [NASDAQ: ANIX] stock has seen the most recent analyst activity on December 23, 2022, when Chardan Capital Markets initiated its Buy rating and assigned the stock a price target of $8. Previously, H.C. Wainwright started tracking the stock with Buy rating on April 12, 2021, and set its price target to $11.

Anixa Biosciences Inc [ANIX] stock has fluctuated between $2.14 and $5.13 over the past year. Currently, Wall Street analysts expect the stock to reach $7.5 within the next 12 months. Anixa Biosciences Inc [NASDAQ: ANIX] shares were valued at $3.31 at the most recent close of the market. An investor can expect a potential return of 126.59% based on the average ANIX price forecast.

Analyzing the ANIX fundamentals

Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -87.94%, Pretax Profit Margin comes in at -80.17%, and Net Profit Margin reading is -79.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.54, Equity is -0.52 and Total Capital is -0.66. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.25 points at the first support level, and at 3.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.41, and for the 2nd resistance point, it is at 3.52.

Ratios To Look Out For

For context, Anixa Biosciences Inc’s Current Ratio is 11.31. In addition, the Quick Ratio stands at 11.31 and the Cash Ratio stands at 0.61.

Transactions by insiders

Recent insider trading involved Titterton Lewis H jr, Director, that happened on Jul 30 ’24 when 21646.0 shares were purchased. Director, Titterton Lewis H jr completed a deal on Jul 31 ’24 to buy 5580.0 shares. Meanwhile, Director Titterton Lewis H jr bought 7700.0 shares on Jul 26 ’24.

Related Posts